Outcomes of Gestational Choriocarcinoma Treatment in Mongolia: A 15-Year Retrospective Analysis

Overview

This study evaluates the clinical characteristics and treatment outcomes of gestational choriocarcinoma in Mongolia. The findings indicate higher complete remission rates and lower mortality in patients treated after the implementation of EMA/CO chemotherapy.

Background

Gestational choriocarcinoma is a malignant form of gestational trophoblastic disease, characterized by aggressive behavior and potential for rapid metastasis. Its incidence varies globally, with higher rates observed in certain regions, including Mongolia. Understanding treatment outcomes and patterns is crucial for optimizing management strategies and improving patient prognosis.

Data Highlights

Key Findings

• 84.8% of patients presented with vaginal bleeding as the primary symptom.
• The lungs were identified as the most common site of metastasis.
• Complete remission rates improved significantly from 69.7% to 97.0% after EMA/CO implementation (p = 0.006).
• Disease-related mortality decreased from 30.3% to 3.0% post-implementation (p = 0.006).
• Chemoresistance and relapse rates decreased, although not statistically significant.
• Metastatic disease remains a key determinant of prognosis.

Clinical Implications

The introduction of EMA/CO chemotherapy has led to improved treatment outcomes for gestational choriocarcinoma in Mongolia.

Conclusion

The study demonstrates improvements in treatment outcomes for gestational choriocarcinoma following the implementation of EMA/CO therapy.

Related Resources & Content

1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Comparative Analysis of Early Intervention and Monitoring in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2. Gastric Cancer, 2023 -- Genomic Characteristics and Potential Treatment Targets in Gastric Cancer Associated with Alpha-Fetoprotein Production
3. Gastric Cancer, 2023 -- Outcomes of Conversion Therapy in Gastric Cancer Patients with Peritoneal Metastasis: Findings from a Large Retrospective Cohort Analysis
4. The ASCO Post — Improved Outcomes in Patients With Germ Cell Testicular Tumors in the Modern Era
5. American College of Radiology ACR Appropriateness Criteria® Gestational Trophoblastic Disease
6. Diagnosis and management of gestational trophoblastic disease: 2025 update - PMC
7. https://www2.healthservice.hse.ie/files/138/
8. Checking your browser - reCAPTCHA
9. Diagnosis and management of gestational trophoblastic disease: 2021 update - PMC
10. Strategies for managing EMA/CO resistant in gestational trophoblastic neoplasia a systematic review and meta analysis - PubMed
11. Strategies for managing EMA/CO resistant in gestational trophoblastic neoplasia a systematic review and meta analysis | Discover Oncology | Springer Nature Link
12. New immunotherapy option emerges for low-risk GTN